The aim is to demonstrate that preoperative exercises (prehabilitation) using blood-flow restriction training (BFRT) is safe, well tolerated, improves muscle function, decreases functional limitation, and increases physical activity in older adults awaiting total knee replacement (TKR).
Twenty individuals ≥60 years old awaiting TKR due to diagnosis of end-stage knee osteoarthritis who meet the inclusion/exclusion criteria will be invited to participate in a 6 weeks of low-intensity BFRT prehabilitation. We will assess muscle functional (i.e., cross-sectional area and intramuscular fatty content) using computerized tomography, quadriceps muscle strength using an isokinetic dynamometer, a battery of performance-based physical function, self-reported physical function and quality of life, and biomarkers of inflammation using blood serum. Feasibility assessment will be done by looking at safety (i.e., adverse events), compliance, and attrition rate.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
16
Participants will be performing low-resistance exercise with (BFRT). Intervention will start at least seven days after initial evaluation, so it does not influence measures of real-time physical activity. We will use a log to register exercise completion and to record bilateral knee pain before, during and after each intervention session
UT Health San Antonio- Dept. of Physical Therapy
San Antonio, Texas, United States
Quadricep Muscle Strength
Changes in strength will be measured using an isokinetic dynamometer. Quadriceps femoris maximum voluntary isometric contraction (MVIC) as torque output (Nm) will be measured. Subjects will be seated in the dynamometer's chair with their knee at 60 degrees of flexion.
Time frame: Baseline, 8 weeks and 16 weeks
Thigh muscles composition
Change in thigh muscles % fat-free mass and % fat mass will be measured using a DXA scan.
Time frame: Baseline, 8 weeks and 16 weeks
Thigh muscle volume
Change in thigh muscles cross-sectional area (volume) will be measured using a DXA scan.
Time frame: Baseline, 8 weeks and 16 weeks
Self-selected Gait Speed
Subject will walk a 4-meter walkway at a self-selected pace. Time to complete task will be recorded.
Time frame: Baseline, 8 weeks and 16 weeks
Timed up and go Test
Subject will get up from a chair, walk 3 meters, turn around and walk back to and sit on the chair. Time to complete task will be recorded.
Time frame: Baseline, 8 weeks and 16 weeks
30-second chair stand test
Subject will perform sit-to-stand from a standard chair for 30 seconds. Number of times of completed sit-to-stand in 30 seconds will be recorded.
Time frame: Baseline, 8 weeks and 16 weeks
Stair climb test
Subject will climb up and down a flight of stairs (11 steps). Time to complete task will be recorded.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline, 8 weeks and 16 weeks
6-minute Walk Test
Subjects will cover as much as they can while walking on a flat, unobstructed path for 6 minutes.
Time frame: Baseline, 8 weeks and 16 weeks
Patient-Reported Physical Outcome
Patient-Reported Physical Outcome will be assessed using PROMIS® (Patient-Reported Outcomes Measurement Information System), which is used to evaluate and monitor physical, mental, and social health in persons with several conditions.
Time frame: Baseline, 8 weeks and 16 weeks
Health Related Quality of Life (RAND-36)
the RAND-36 Questionnaire is comprised of 36 items that assess eight health concepts: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions.
Time frame: Baseline, 8 weeks and 16 weeks
Real-time Physical Activity
An activity monitor will be worn for 7 days and physical activity (i.e., daily number of steps) will be tracked.
Time frame: Baseline, 8 weeks and 16 weeks
Inflammatory Biomarkers
Change in 'MILLIPLEX® MAP Human High Sensitivity T Cell Magnetic Bead Panel' to assess a panel of 8 inflammatory biomarkers: Interleukin (IL)-1β, IL-2, IL-5, IL-6, IL-10, IL-12p70, IL-13 and Interferon-γ.
Time frame: Baseline, 8 weeks and 16 weeks